Core Viewpoint - Rentokil Initial plc is facing a class action lawsuit due to alleged misleading statements and failures to disclose critical information regarding its integration of Terminix Global Holdings, which negatively impacted its business performance and stock price [3][4][5][6]. Group 1: Class Action Details - The class action represents investors who purchased Rentokil securities between December 1, 2023, and September 10, 2024, with a deadline for filing a lead plaintiff motion set for January 27, 2025 [1]. - The lawsuit claims that Rentokil made false statements and failed to disclose significant integration challenges with Terminix, jeopardizing its business operations [4]. Group 2: Financial Impact - Rentokil's organic revenue growth in North America was reported at only 1.5% year-over-year on April 18, 2024, significantly below the company's earlier guidance of 2% for Q1 and 2% to 4% for the full year [5]. - Following the disappointing revenue growth announcement, Rentokil's American Depositary Shares (ADS) price dropped by more than 9% [5]. - An unscheduled trading update on September 11, 2024, forecasted just 1% organic revenue growth for the second half of 2024, leading to a further decline of over 21% in the ADS price [6].
Rentokil Initial plc Investors: Please contact the Portnoy Law Firm to recover your losses. January 27, 2025 Deadline to file Lead Plaintiff Motion.